top of page
Galafold
Client
Year
Audience
Disease
Amicus
2018
Patients
Fabry Disease (Rare Lysosomal Disease)
Objective: Position Galafold, the first and only oral therapy available, as the the treatment that respects patients' time in a disease that is progressive and unpredictable.
Tactics: Staged-approach website, library of educational print pieces, MOA videos, patient ambassador photoshoot, patient story videos, in-office educational materials, mailers and patient kits.
bottom of page